Cocrystal Pharma (COCP) Current Leases (2018 - 2026)
Cocrystal Pharma (COCP) reported Current Leases of $343000.0 for Q1 2026, up 11.0% on a YoY basis from $309000.0 in Q1 2025, and up 2.69% sequentially from $334000.0 in Q4 2025.
Cocrystal Pharma (COCP) Current Leases (2018 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 9 years of Current Leases data on file, last reported at $343000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 11.0% year-over-year to $343000.0; the trailing twelve-month figure through Mar 2026 stood at $343000.0 (up 11.0% YoY), and the FY2025 full-year result was $334000.0, up 10.96% from the prior year.
- Current Leases climbed to $343000.0 in Q1 2026, from $334000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $343000.0 in Q1 2026 to a low of $14000.0 in Q3 2022.
- A 5-year average of $231117.6 and a median of $240000.0 in 2023 frame the typical range for Current Leases.
- Across the five-year window, Current Leases slumped 51.72% in 2022 and soared 742.86% in 2023, its largest moves.
- Tracing COCP's Current Leases over 5 years: stood at $233000.0 in 2022, then increased by 3.0% to $240000.0 in 2023, then increased by 25.42% to $301000.0 in 2024, then gained by 10.96% to $334000.0 in 2025, then increased by 2.69% to $343000.0 in 2026.
- Business Quant data shows COCP's Current Leases at $343000.0 in Q1 2026, $334000.0 in Q4 2025, and $326000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.61 Mn |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | 343,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 343,000.00 |
| Dec 31, 2025 | 334,000.00 |
| Sep 30, 2025 | 326,000.00 |
| Jun 30, 2025 | 317,000.00 |
| Mar 31, 2025 | 309,000.00 |
| Dec 31, 2024 | 301,000.00 |
| Sep 30, 2024 | 293,000.00 |
| Jun 30, 2024 | 251,000.00 |
| Mar 31, 2024 | 240,000.00 |
| Dec 31, 2023 | 240,000.00 |
| Sep 30, 2023 | 118,000.00 |
| Jun 30, 2023 | 166,000.00 |
| Mar 31, 2023 | 208,000.00 |
| Dec 31, 2022 | 233,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 21,000.00 |
| Mar 31, 2022 | 215,000.00 |
| Dec 31, 2021 | 209,000.00 |
| Sep 30, 2021 | 29,000.00 |
| Jun 30, 2021 | 33,000.00 |